ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why Semaglutide is on this study

  • The record lists it as a treatment, written “Semaglutide (Wegovy) weekly injection”.
  • Claude Opus 5.5 judged it tested: part of what the study tests. Nov 1, 2026, 10:38 AM UTC“Semaglutide against placebo in hypothalamic obesity”
  • The role rule says the same.
  • So Semaglutide's page lists this study under “Testing it”.
3 links0 made here, not in the record4 judgments2 judges (the rules as one: Rule based)2 record changes seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govReplaced, or read an older version
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07845994SEMAFORCRANIO :Multicenter, Double-blind,Parallel, RandomizedControlled Trial of theEfficacy of Semaglutide inHypothalamic ObesitySecondary toUniversity Hospital, AngersPhase 3 · not yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 29 · ClinicalTrials.gov record · Version of 2026-09-29Nov 19 · ClinicalTrials.gov record · Version of 2026-11-19Version of 2026-11-19CONDITIONSCraniopharyngiomaThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionSexual InfantilismThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSSemaglutideEntry “Semaglutide (Wegovy) weekly in…›Nov 1 · Claude Opus 5.5 · TestedNov 1 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
2 versions of the record seen on ClinicalTrials.gov, Sep 29–Nov 19 · changes seen, not judgments
Nov 1SemaglutideClaude Opus 5.5TestedReplaced
Nov 1SemaglutideClaude Opus 5.5TestedCurrent
Nov 18SemaglutideRule based · role ruleTestedAgrees
As of nowCraniopharyngiomaRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.